Jiang, Zefei
Chinese PLA General Hospital
2 papers on CoChatORCID 0000-0002-4295-0173
Most cited papers
- Verified
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jiang, Z., Li, W., Hu, X., Zhang, Q., Sun, T., Cui, S., Wang, S., Ouyang, Q., Yin, Y., Geng, C., et al. (2019) · The Lancet Oncology
Advanced Breast Cancer TherapiesBreast Cancer Treatment Studies
Cited by 270
- Verified
Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial
Liu, J., Liu, Q., Li, Y., Li, Q., Su, F., Yao, H., Su, S., Wang, Q., Jin, L., Wang, Y., et al. (2020) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersBreast Cancer Treatment Studies
Cited by 183
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free